- Requirements: Required if traveling from a country with risk of YFV transmission and ≥9 months of age, including transit >12 hours in an airport located in a country with risk of YFV transmission. 1
- Recommendations: None.
- Areas with malaria: All.
- Estimated relative risk of malaria for US travelers: Moderate.
- Drug resistance 4: Chloroquine.
- Malaria species: P. falciparum >90%, P. vivax up to 5%, P. ovale up to 5%.
- Recommended chemoprophylaxis: Atovaquone-proguanil, doxycycline, or mefloquine.
Brunette, Gary W., editor. "Zimbabwe." CDC Yellow Book, Centers for Disease Control and Prevention, 2018. Relief Central, relief.unboundmedicine.com/relief/view/cdc-yellow-book/204439/all/Zimbabwe.
Zimbabwe. In: Brunette GW, ed. CDC Yellow Book. Centers for Disease Control and Prevention; 2018. https://relief.unboundmedicine.com/relief/view/cdc-yellow-book/204439/all/Zimbabwe. Accessed April 2, 2020.
Zimbabwe. (2018). In Brunette, G. W. (Ed.), CDC Yellow Book. Centers for Disease Control and Prevention. Retrieved April 02, 2020, from https://relief.unboundmedicine.com/relief/view/cdc-yellow-book/204439/all/Zimbabwe
Zimbabwe [Internet]. In: Brunette GW, editors. CDC Yellow Book. Centers for Disease Control and Prevention; 2018. [cited 2020 April 02]. Available from: https://relief.unboundmedicine.com/relief/view/cdc-yellow-book/204439/all/Zimbabwe.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Zimbabwe ID - 204439 ED - Brunette,Gary W, BT - CDC Yellow Book UR - https://relief.unboundmedicine.com/relief/view/cdc-yellow-book/204439/all/Zimbabwe PB - Centers for Disease Control and Prevention DB - Relief Central DP - Unbound Medicine ER -